{"id":"W2891798328","doi":"10.1200/jco.2018.36.15_suppl.8000","title":"Once-weekly vs twice-weekly carfilzomib (K) dosing plus dexamethasone (d) in patients with relapsed and refractory multiple myeloma (RRMM): Results of the randomized phase 3 study A.R.R.O.W.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Leukemia & Lymphoma Society of Canada","funders":"","keywords":"Medicine; Carfilzomib; Internal medicine; Clinical endpoint; Lenalidomide; Regimen; Interim analysis; Multiple myeloma; Tolerability; Neutropenia; Dexamethasone; Gastroenterology; Adverse effect; Randomized controlled trial; Toxicity","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001960814,0.0008231704,0.002240657,0.0003634296,0.0004000184,0.0008199723,0.000741666,0.00110458,0.002885512],"category_scores_gemma":[0.001459689,0.000526324,0.001632878,0.0004029903,0.0008124007,0.0009781725,0.0003456215,0.002659502,0.0004728285],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008204971,"about_ca_system_score_gemma":0.001188932,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009592971,"about_ca_topic_score_gemma":0.002854333,"domain_scores_codex":[0.9992348,0.0004581831,0.00005296156,0.00008829507,0.00005181262,0.000113962],"domain_scores_gemma":[0.9987575,0.0003569002,0.0003162737,0.00009215614,0.00004461887,0.0004325733],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9550136,0.01082324,0.001717373,0.0002193653,0.0005179212,0.00003176762,0.00005931261,0.0004070445,0.003906761,0.00003998385,0.0005146429,0.02674906],"study_design_scores_gemma":[0.694344,0.2958632,0.007062966,0.00002547755,0.0005542675,0.00006188569,0.00003191885,0.0005737593,0.0006567499,0.0001179607,0.0006894245,0.00001840674],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945304,0.002740305,0.0002377094,0.0004886448,0.0001717047,0.0008623739,0.0003054046,0.00004264208,0.000620848],"genre_scores_gemma":[0.9957859,0.001154776,0.0006014518,0.0005047834,0.0001996237,0.0007290826,0.0003068365,0.00001147962,0.0007059199],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002885512,"threshold_uncertainty_score":0.0103699,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08809992328939925,"score_gpt":0.4424007583133508,"score_spread":0.3543008350239515,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}